Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive gabapentin versus intravenous paracetamol for hemodynamic stability during adult cardiac surgery
IRCT20221210056764N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of gabapentin and acetaminophen in coronary arteriosclerosis (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Hemodynamic stability, Heart rate and 1 more. Started Mar 2023; status: completed.
02
Drugs
gabapentinacetaminophen
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20221210056764N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221210056764N1.